Durrant, Linda Gillian,Brentville, Victoria Anne,Metheringham, Rachel Louise
申请号：
AU2016295337
公开号：
AU2016295337A1
申请日:
2016.07.19
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to modified citrullinated enolase peptides that can be used as targets for cancer immunotherapy. These peptides can be used as vaccines or as targets for monoclonal antibody (mAb) therapy. Such vaccines or mAbs may be used in the treatment of cancer.
